← Leaderboards
Guodong Cao
University Of Pittsburgh At Pittsburgh
$6,920,473
Attributed
$8,097,076
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2009–25$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,097,076 · 6
VA$0 · 4
By mechanism
RF1$4,582,906 · 2
R01$2,170,895 · 2
P01$980,385 · 1
R21$362,890 · 1
I01$0 · 4
Top collaborators
- Dandan Sun1 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Fabrisia Ambrosio$15,553,662
- Radosveta P Koldamova$12,908,953
- Ruth Anne Stetler$1,726,162
- Jun Chen$22,616,112
- Robert S. Clark$12,893,742
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoProteinsInfarctionOverexpressionIschemiaMiddle Cerebral Artery OcclusionIschemic StrokeStrokeBrainProductionClinically RelevantPost StrokeNeuronsIn VitroRecombinantsDisabilityIschemic Brain InjuryRecovery Of FunctionCerebral IschemiaNeuroprotectionNeurological OutcomeGenerationsNeurological RecoveryCells
Grant awards (29)
SPAK-NKCC1 complex and the blood-CSF barrier dysregulation in VCID$2,353,206
RF1 · FY2025 · NS
Innate immunity and ischemic stroke$0
I01 · FY2025 · VA · contact PI
White Matter Restoration in Vascular Cognitive Impairment and dementia$561,842
R01 · FY2024 · NS · contact PI
Reprogrammed cell therapy for white matter restoration in aged brain ischemia$0
I01 · FY2023 · VA · contact PI
Reprogrammed cell therapy for white matter restoration in aged brain ischemia$0
I01 · FY2022 · VA · contact PI
Reprogrammed cell therapy for white matter restoration in aged brain ischemia$0
I01 · FY2021 · VA · contact PI
White Matter Restoration in Vascular Cognitive Impairment and dementia$2,229,700
RF1 · FY2020 · NS · contact PI
Reprogrammed cell therapy for white matter restoration in aged brain ischemia$0
I01 · FY2020 · VA · contact PI
A Novel Intervention for Cerebral Ischemia$0
I01 · FY2019 · VA · contact PI
Reprogrammed cell therapy for white matter restoration in aged brain ischemia$0
I01 · FY2019 · VA · contact PI
White Matter Protection in Cerebral Ischemia$336,875
R01 · FY2017 · NS · contact PI
A Novel Intervention for Cerebral Ischemia$0
I01 · FY2017 · VA · contact PI
White Matter Protection in Cerebral Ischemia$336,875
R01 · FY2016 · NS · contact PI
A Novel Intervention for Cerebral Ischemia$0
I01 · FY2016 · VA · contact PI
White Matter Protection in Cerebral Ischemia$336,875
R01 · FY2015 · NS · contact PI
A Novel Intervention for Cerebral Ischemia$0
I01 · FY2015 · VA · contact PI
White Matter Protection in Cerebral Ischemia$264,834
R01 · FY2014 · NS · contact PI
A Novel Intervention for Cerebral Ischemia$0
I01 · FY2014 · VA · contact PI
Neurorecovery Effect of Novel Modified Erythropoietin on Ischemic Brain Injury$0
I01 · FY2014 · VA · contact PI
Neurorecovery Effect of Novel Modified Erythropoietin on Ischemic Brain Injury$0
I01 · FY2014 · VA · contact PI
White Matter Protection in Cerebral Ischemia$333,594
R01 · FY2013 · NS · contact PI
Molecular Core$288,882
P01 · FY2013 · NS · contact PI
Molecular Core$177,353
P01 · FY2012 · NS · contact PI
Molecular Core$173,469
P01 · FY2011 · NS · contact PI
Molecular Core$171,946
P01 · FY2010 · NS · contact PI
Novel Modified Erythropoietins for the Treatment of Ischemic Brain Injury$164,046
R21 · FY2010 · NS · contact PI
Novel Modified Erythropoietins for the Treatment of Ischemic Brain Injury$198,844
R21 · FY2009 · NS · contact PI
Molecular Core$168,735
P01 · FY2009 · NS · contact PI
Neurorecovery Effect of Novel Modified Erythropoietin on Ischemic Brain Injury$0
I01 · FY2009 · VA · contact PI